全文获取类型
收费全文 | 24251篇 |
免费 | 2134篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 241篇 |
儿科学 | 844篇 |
妇产科学 | 775篇 |
基础医学 | 3218篇 |
口腔科学 | 480篇 |
临床医学 | 2632篇 |
内科学 | 4411篇 |
皮肤病学 | 266篇 |
神经病学 | 2551篇 |
特种医学 | 1041篇 |
外科学 | 2937篇 |
综合类 | 487篇 |
一般理论 | 30篇 |
预防医学 | 2816篇 |
眼科学 | 467篇 |
药学 | 1903篇 |
中国医学 | 22篇 |
肿瘤学 | 1289篇 |
出版年
2022年 | 226篇 |
2021年 | 458篇 |
2020年 | 339篇 |
2019年 | 441篇 |
2018年 | 521篇 |
2017年 | 425篇 |
2016年 | 433篇 |
2015年 | 482篇 |
2014年 | 673篇 |
2013年 | 963篇 |
2012年 | 1306篇 |
2011年 | 1333篇 |
2010年 | 726篇 |
2009年 | 612篇 |
2008年 | 1082篇 |
2007年 | 1087篇 |
2006年 | 1034篇 |
2005年 | 987篇 |
2004年 | 827篇 |
2003年 | 900篇 |
2002年 | 798篇 |
2001年 | 655篇 |
2000年 | 637篇 |
1999年 | 601篇 |
1998年 | 281篇 |
1997年 | 225篇 |
1996年 | 210篇 |
1995年 | 209篇 |
1994年 | 189篇 |
1993年 | 164篇 |
1992年 | 456篇 |
1991年 | 479篇 |
1990年 | 459篇 |
1989年 | 429篇 |
1988年 | 441篇 |
1987年 | 448篇 |
1986年 | 367篇 |
1985年 | 382篇 |
1984年 | 302篇 |
1983年 | 254篇 |
1982年 | 172篇 |
1979年 | 285篇 |
1978年 | 226篇 |
1977年 | 167篇 |
1976年 | 198篇 |
1974年 | 208篇 |
1973年 | 192篇 |
1972年 | 183篇 |
1969年 | 188篇 |
1968年 | 161篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
ABSTRACTCommunication between health professionals and patients is an intergroup phenomenon where the health professional has the most power and status. Over the past few decades, there has been a steady increase in the availability to patients of information about healthcare and specific diseases on the Internet. In this paper, we ask whether the use of Internet health information assists patients to manage their consultations with health professionals better and whether it alters the intergroup dynamic by providing a more equal status for patients. In this study 370 participants from Australia and Canada completed a survey that included a ‘willingness to communicate with health professionals’ scale. They also commented on their use and trust of Internet health information. Thematic analysis suggests that patients’ use of Internet health information serves as a broker between patients and their health provider in health consultations. We discuss the implications of these findings for health practitioners as they address how easier Internet access influences patient interactions with health professionals. We consider future research directions these finding provide in explaining communication behaviour in this context. 相似文献
2.
3.
Objectives
Iatrogenic injury of the Profunda Femoris Artery (PFA) at time of hip fixation surgery can increase morbidity and mortality and prolong the hospital stay. This is an injury that tends to pass unnoticed as a cause of postoperative deterioration despite being frequently reported in the literature. Our study aims to describe the anatomy of the PFA in relation to the medial femoral cortex with specific emphasis on its orientation relative to the position of a sliding hip screw side plate construct. By doing so we are able to present clear guidance to orthopaedic surgeons on how to avoid iatrogenic PFA injury at the time of hip fracture fixation.Methods
Using Computed Tomography Angiographic (CTA) studies, the course of the PFA in relation to the medial femoral cortex was traced in 44 patients (28 males and 16 females) with mean age of 65.6 years. Coronal and axial CT sections were cross-linked to specify the position of the PFA at 1?cm intervals.Results
The course of the artery could be divided into three parts relative to a fixed reference point. Proximal and distal parts of the artery were in a safer position in comparison to the middle part of the artery that was found very close to the femoral cortex and along the coronal axis of the femur (mean angle 2.9° from the femoral coronal axis and 13.8?mm from the medial femoral cortex). Using the commercially available side plate constructs, this part of the artery corresponded to the distal part of the plate (third and fourth holes).Conclusion
Special attention needs to be practiced by the operating surgeon while drilling into the third and fourth holes of the side plate. 相似文献4.
C. Lindsay DeVane 《Pharmacotherapy》2016,36(9):953-954
5.
6.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
7.
8.
Adrenal disorders in pregnancy. 总被引:1,自引:0,他引:1
9.
10.
Dr. Michael Gosland Pharm.D. Dr. Bert Lum Pharm.D. Dr. Julia Schimmelpfennig Pharm.D. Dr. James Baker Pharm.D. Dr Michael Doukas M.D. 《Pharmacotherapy》1996,16(1):16-39
Cisplatin in combination with other cytotoxic agents is the backbone for a potential cure of testicular germ cell neoplasms and is a critical factor in the substantial activity observed in the treatment of small cell lung cancer, bladder cancer, and ovarian germ cell tumors. Resistance to cisplatin at the onset of treatment or at relapse limits its curative potential, however. Laboratory studies using both cells selected for cisplatin resistance by exposure to sublethal concentrations and biopsy specimens from patients' tumors provide insights for the potential mechanisms of resistance. The mechanisms identified in vitro include a complex and wide array of related and unrelated pathways such as alterations in cellular drug transport, enhanced DNA repair dependent and independent of signal transduction pathways, and enhanced intracellular detoxification such as glutathione and metallothionein systems. Studies of these mechanisms have identified a number of agents with known potential for administration to humans and that reverse cisplatin resistance in vitro; for example, reversal of cellular accumulation defects by dipyridamole; inhibition of DNA repair by hydroxyurea, pentoxifylline, and novobiocin; inhibition of the glutathione system by ethacrynic acid and buthionine sulfoximine; and inhibition of signal transduction pathways by cyclosporine, tamoxifen, and calcium channel-blocking agents. Current phase I clinical trials are focusing on the most effective doses and schedules to administer these agents in combination with cisplatin. Initial uncontrolled trials in limited numbers of patients suggest that the addition of modulators of cisplatin has the potential to reverse resistance in patients previously failing therapy. Another promising avenue for circumventing cisplatin resistance is the development of noncross-resistant platinum analogs. 相似文献